about an Infectious Disease called "COVID-19"...and I support those criticisms using personal consultation with true experts in the fields that are most involved with that disease...i.e Infectious Diseases, and Pulmonary/Critical Care (e.g. "ICU")...Baron has demonstrated no knowledge of those fields (note: our ID and ICU specialists don't ever want to hear his name again)
As for HCQ...chew on the attached article...
>HCQ only deals with the ACE2 protein
>Human Lung cells have both ACE2 and TMPRSS2 proteins for entry...so HCQ can't stop the infection
>Once inside the lung cell its RNA needs to be 'snipped' into smaller segments that then can be spread to other cells...HCQ does NOTHING to stop that process of replication.
>PAXLOVID is designed to inhibit that 'snipping', and do it for an extended period.
Bottom line...HCQ doesn't work...PAXLOVID does...proven 88% effective in keeping high-risk patients out of the hospital.
Link: https://www.pcf.org/blog/understanding-the-relationship-between-tmprss2-and-covid-19/